{"id":"726065718920-12","name":"Astellas Pharma Europe Limited","registrationDate":"2015-09-24T16:26:50.974+02:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.astellas.eu","country":"United kingdom","headAddress":"2000 Hillswood Drive","headCity":"Chertsey","headPostCode":"KT16 0RS","headPhone":"(44)20 33 79 82 22","boss":"Daniel Schulze","bossTitle":"Mr","bossPosition":"Senior Vice President &amp; General Counsel","membersCount":2,"membersFTE":"1.5","membership":"EFPIA&#xd;\nNational pharmaceutical associations","memberOrga":"EFPIA&#xd;\nNational pharmaceutical associations","goal":"Providing high quality medicines in areas of high unmet medical need","acronym":"APEL","interests":"Business and Industry, Competition, Consumers, Customs, Economy, finance and the euro, Employment and Social Affairs, Enlargement, Environment, External Relations, Institutional affairs, International co-operation and development, Public Health, Research and innovation, Taxation, Trade","euInitiatives":"All relevant pharmaceutical and health care initiatives, including Falsified Medicines Directive, Organ supply Directive, European Commission Incentives Review, Member State collaboration in the area of medicines pricing, EUnetHTA, orphan disease legislation, European Medicines Agency and regulatory policy, etc.","lastUp":"2019-04-22T20:08:53.240+02:00","customers":"","costAbsolu":"","costRange":"700000-799999","turnoverAbsolu":0,"turnoverRange":""}